NuVasive

From WikiCover

Jump to: navigation, search

NuVasive is a medical device company that designs, develops, and markets products for the surgical treatment of spine disorders. The company's product portfolio is focused on applications in the over $3.6 billion U.S. spine fusion market. NuVasive's current principal product offering includes a minimally disruptive surgical platform called Maximum Access Surgery, or MAS, as well as a growing offering of cervical and motion preservation products.

[edit] Maximum Access Surgery

The MAS platform offers advantages for both patients and surgeons such as reduced surgery and hospitalization time and faster recovery. MAS combines three categories of current product offerings: NeuroVision a proprietary software-driven nerve avoidance system; MaXcess a unique split-blade design retraction system; and specialized implants, like SpheRx and CoRoent, that collectively minimize soft tissue disruption during spine surgery while allowing maximum visualization and surgical reproducibility. NuVasive's product offering is also focused on cervical internal fixation products and its R&D pipeline emphasizes both MAS and motion preservation


Website: http://www.nuvasive.com/